loader
Please Wait
Applying Filters...
menu
    • menu

    Drug Product Composition: Invokana

    Menu

    Invokana

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 2,753Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 205879 / DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 50MG;500MG

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    canagliflozin(UNII: 0SAC974Z85)
    (canagliflozin anhydrous - UNII:6S49DGR869)     		canagliflozin anhydrous150mg | 150mg | 50mg | 50mg
    metformin hydrochloride(UNII: 786Z46389E)
    (metformin - UNII:9100L32L2N)     		metformin hydrochloride1000mg | 500mg | 500mg | 1000mg

    Inactive Ingredients

    Ingredient Name
    Janssen Pharmaceuticals, Inc.
    anhydrous lactose(3SY5LH9PMK)
    croscarmellose sodium(M28OL1HH48)
    ferric oxide red(1K09F3G675)
    ferric oxide yellow(EX438O2MRT)
    ferrosoferric oxide(XM0M87F357)
    HYDROXYPROPYL CELLULOSE (1200000 MW)(RFW2ET671P)
    hypromellose, unspecified(3NXW29V3WO)
    magnesium stearate(70097M6I30)
    microcrystalline cellulose(OP1R32D61U)
    polyethylene glycol, unspecified(3WJQ0SDW1A)
    polyvinyl alcohol, unspecified(532B59J990)
    talc(7SEV7J4R1U)
    titanium dioxide(15FIX9V2JP)